First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation RAPNO LGG overall response.
Pediatric Brain Tumor Foundation, Author at Noozhawk noozhawk.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from noozhawk.com Daily Mail and Mail on Sunday newspapers.
New Model of Key Brain Tumor Feature Could Help Scientists Understand How To Develop New Treatments goodmenproject.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from goodmenproject.com Daily Mail and Mail on Sunday newspapers.
Researchers at the University of Michigan Health Rogel Cancer Center are exploiting a unique biological feature of glioblastoma to gain a better understanding o